Enanta Pharmaceuticals misses by $0.74, misses on revenues

Enanta Pharmaceuticals (ENTA): FQ2 EPS of -$0.28 misses by $0.74.

Revenue of $2.2M (+80.6% Y/Y) misses by $5.95M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs